Risk Factors for Cervical Lymph Node Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma.
lymph node metastasis
papillary thyroid microcarcinoma
recurrence-free survival
risk factors
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
08 Aug 2022
08 Aug 2022
Historique:
received:
27
06
2022
revised:
26
07
2022
accepted:
04
08
2022
entrez:
12
8
2022
pubmed:
13
8
2022
medline:
13
8
2022
Statut:
epublish
Résumé
Papillary thyroid microcarcinoma (PTMC) typically has an indolent course and excellent prognosis. Nonetheless, a subset of PTMC carries a risk of lymph node metastasis (LNM) and local recurrence. PTC from the Middle Eastern population is unique with respect to demographic and clinico-pathological characteristics as compared to other ethnicities of the world. The risk factors of LNM in PTMC patients of Middle Eastern ethnicity have not been fully explored. The present study aims to investigate the influencing factors of LNM in Middle Eastern PTMC patients and its predictive impact on patient's outcome. A total of 226 confirmed PTMC cases were selected in this retrospective study. The correlation between clinico-pathological, as well as molecular, characteristics and LNM was evaluated. Multivariate analysis was performed by logistic regression and Cox proportional hazards models. Among the 226 patients, the rate of LNM was 43.8% (99/226). Bilaterality, multifocality, gross extrathyroidal extension (ETE), and intermediate-to-high American Thyroid Association (ATA) risk tumors were significantly associated with LNM in PTMC. Multivariate logistic regression analysis showed that bilaterality and gross ETE were independent predictive factors for LNM in PTMC. The recurrence-free survival (RFS) was shorter in PTMC with LNM compared to those without LNM (
Identifiants
pubmed: 35956227
pii: jcm11154613
doi: 10.3390/jcm11154613
pmc: PMC9369489
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
CA Cancer J Clin. 2012 Mar-Apr;62(2):118-28
pubmed: 22281605
Clin Otolaryngol. 2010 Apr;35(2):118-24
pubmed: 20500581
J Clin Endocrinol Metab. 2014 Aug;99(8):2834-43
pubmed: 24828487
PLoS One. 2015 Mar 25;10(3):e0121514
pubmed: 25807528
BMC Endocr Disord. 2019 Nov 15;19(1):124
pubmed: 31729977
Exp Ther Med. 2020 Dec;20(6):243
pubmed: 33178341
Cancer. 2003 Jul 1;98(1):31-40
pubmed: 12833452
Int J Surg. 2018 Jul;55:98-102
pubmed: 29803769
Cancers (Basel). 2021 Feb 01;13(3):
pubmed: 33535609
Cancers (Basel). 2020 Dec 03;12(12):
pubmed: 33287340
Ann Saudi Med. 2019 Sep-Oct;39(5):345-349
pubmed: 31580696
Endocr J. 2012;59(4):305-11
pubmed: 22240889
Endocr Connect. 2022 Feb 16;11(2):
pubmed: 35044932
BMJ. 2013 Aug 27;347:f4706
pubmed: 23982465
BMC Cancer. 2008 Oct 14;8:296
pubmed: 18851763
Int J Endocrinol. 2019 Jan 15;2019:8579828
pubmed: 30774660
Thyroid. 2012 Nov;22(11):1144-52
pubmed: 23083442
Head Neck. 2016 Apr;38 Suppl 1:E1172-6
pubmed: 26268535
World J Surg. 2013 Feb;37(2):385-91
pubmed: 23073506
Nucl Med Commun. 2019 May;40(5):477-483
pubmed: 30973839
J Endocrinol Invest. 2018 Apr;41(4):403-409
pubmed: 28884301
Clin Endocrinol (Oxf). 2017 Jun;86(6):845-851
pubmed: 28273370
Cureus. 2020 May 10;12(5):e8044
pubmed: 32528780
Surgery. 2010 Dec;148(6):1147-52; discussion 1152-3
pubmed: 21134545
Head Neck. 2015 Sep;37(9):1336-43
pubmed: 24821456
Asian J Surg. 2019 Apr;42(4):563-570
pubmed: 30078501
Endocrinol Metab Clin North Am. 2019 Mar;48(1):1-22
pubmed: 30717895
Front Oncol. 2021 Sep 30;11:644645
pubmed: 34660255
J Cancer Epidemiol. 2013;2013:965212
pubmed: 23737785
Int J Cancer. 2018 May 15;142(10):2028-2039
pubmed: 29266240
Cancer Biol Med. 2019 Feb;16(1):121-130
pubmed: 31119052
Oncol Lett. 2019 Jan;17(1):183-194
pubmed: 30655754
PLoS One. 2020 Dec 31;15(12):e0244930
pubmed: 33382852
Thyroid. 2020 Aug;30(8):1132-1140
pubmed: 32098591
JAMA. 2017 Apr 4;317(13):1338-1348
pubmed: 28362912
World J Surg. 2015 Oct;39(10):2459-70
pubmed: 26099728
Ear Nose Throat J. 2016 Feb;95(2):73-7
pubmed: 26930333
Front Endocrinol (Lausanne). 2021 Mar 05;12:640565
pubmed: 33746905
Rambam Maimonides Med J. 2016 Jan 28;7(1):
pubmed: 26886958
Front Endocrinol (Lausanne). 2022 Mar 11;13:808298
pubmed: 35360077
Ann Surg Oncol. 2016 Sep;23(9):2866-73
pubmed: 27075321
Thyroid. 2014 Mar;24(3):472-9
pubmed: 23937391
Ann Surg Oncol. 2019 Nov;26(12):3992-4001
pubmed: 31264121
Medicine (Baltimore). 2017 Mar;96(10):e6240
pubmed: 28272218
Front Surg. 2021 Jun 16;8:680493
pubmed: 34222321
J Am Coll Surg. 2020 Apr;230(4):484-491
pubmed: 32220437
Cancers (Basel). 2021 Nov 07;13(21):
pubmed: 34771729
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Hematol Oncol Stem Cell Ther. 2008 Jan-Mar;1(1):14-21
pubmed: 20063523
Front Endocrinol (Lausanne). 2020 Aug 25;11:551
pubmed: 32982963
World J Surg. 2014 Apr;38(4):858-62
pubmed: 24305921
Thyroid. 2009 Jul;19(7):707-16
pubmed: 19348581
J Clin Med. 2021 Sep 09;10(18):
pubmed: 34575184